A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab MK-3475, NSC 776864 in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer

Brief Summary

Type:
Gynecologic - Other

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT03914612

Study #:
STUDY00144675

Start Date:
Dec 12, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03914612

View Complete Trial Details & Eligibility at ClinicalTrials.gov